Total Return chart SciBase Holding AB

Stocks

End-of-day quote Nasdaq Stockholm Other stock markets 2026-07-03			5-day change	1st Jan Change
33.80 ^SEK	+0.30%		+2.58%	-2.03%

07-01	SciBase Holding AB Submits FDA 510(k) to Expand Nevisense Indication for Non-Melanoma Skin Cancer Assessment	CI
06-10	SciBase Holding AB and Castle Biosciences Enroll First Patient in New Study Assessing Early Prediction of Flares in Atopic Dermatitis	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.